Researcher
Peter Bossuyt
- Disciplines:Endocrinology and metabolic diseases, Gastro-enterology and hepatology, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Jun 2015 → Today
Publications
121 - 130 of 155
- A Treat to Target Approach Decreases the Rate of CD-Related Adverse Outcomes versus a Clinical Approach in Patients With Moderate to Severely Active Crohn's Disease: Data From CALM(2017)
Authors: Jean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, Filip Baert, Tomas Vanasek, Ahmet Danalioglu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hebuterne, Simon Travis, et al.
Pages: S321 - S321 - Tofacitinib Is the Right OCTAVE for Ulcerative Colitis.(2017)
Authors: Peter Bossuyt
Pages: 862 - 864 - ECCO IBD curriculum(2017)
Authors: James O Lindsay, Peter M Irving, Gerassimos J Mantzaris, Julián Panés, ECCO Education Committee and ECCO Governing Board, K Katsanos, P Juillerat, G Maconi, P Lakatos, V Annese, et al.
Pages: 1039 - 1043 - Risk Stratification for Surgery in Stricturing Ileal Crohn's Disease: The BACARDI Risk Model(2017)
Authors: Peter Bossuyt, Marc Ferrante, Anthony de Buck van Overstraeten, Dirk Vanbeckevoort, Albert Wolthuis, Isabelle Cleynen, Gert Van Assche, Séverine Vermeire
Pages: 32 - 38 - SUPERIOR ENDOSCOPIC AND DEEP REMISSION OUTCOMES IN ADULTS WITH MODERATE TO SEVERE CROHN'S DISEASE MANAGED WITH TREAT TO TARGET APPROACH VERSUS CLINICAL SYMPTOMS: DATA FROM CALM(2017)
Authors: Jean Frederic Colombel, Remo Panaccione, Peter Bossuyt, Milan Lukas, Filip J Baert, Tomas Vanasek, Ahmet Danalioglu, Gottfried Novacek, Alessandro Armuzzi, Xavier Hebuterne, et al.
Pages: S155 - S155 - DISEASE COURSE AND OPERATIVE RISK AFTER DIAGNOSIS OF ILEAL PENETRATING CROHN'S DISEASE: A COHORT STUDY(2017)
Authors: Peter Bossuyt, Celine Debeuckelaere, Marc Ferrante, Anthony de Buck van Overstraeten, Thibo Billiet, Dirk Vanbeckevoort, Albert Wolthuis, André D'Hoore, Gert Van Assche, Séverine Vermeire
Pages: S1212 - S1212 - EARLY FIBROSTENOSIS IN CROHN'S DISEASE IS ASSOCIATED WITH MULTIPLE SUSCEPTIBILITY LOCI ON IMMUNOCHIP ANALYSIS(2017)
Authors: Tom Holvoet, Peter Bossuyt, Isabelle Cleynen, Isabelle De Kock, Pieter Hindryckx, Séverine Vermeire, Debby Laukens, Martine De Vos
Pages: S982 - S982 - Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases(2017)
Authors: Peter Bossuyt, Marc Ferrante
Pages: 333 - 340 - Primetime for e-health in IBD?(2017)
Authors: Peter Bossuyt
Pages: 133 - 134 - Disease course and operative risk after diagnosis of ileal penetrating Crohn's disease: a cohort study(2017)
Authors: Peter Bossuyt, C Debeuckelaere, Marc Ferrante, A De Buck van Overstraeten, T Billiet, D Vanbeckevoort, Albert Wolthuis, A D'Hoore, Gert Van Assche, Séverine Vermeire
Pages: S209 - S209